Abeclib Tablet

About Abeclib 150 mg Tablet

The tablet Abeclib contains Abemaciclib and is made by Eskayef Pharmaceuticals Ltd. It is not a general-purpose medicine and should only be used under cancer specialist care.

There are 6 brands of Abemaciclib listed in Bangladesh. By unit price, Abeclib is among the cheapest of them. The lowest listed price is Abeza 150 mg Tablet at ৳ 950.00 per unit.

What is Abeclib 150 mg Tablet?

The tablet Abeclib contains Abemaciclib and is made by Eskayef Pharmaceuticals Ltd. Because it is a specialist cancer medicine, it is started and followed by a qualified doctor. Because it is a specialist medicine, the doctor chooses who should receive it and how the course is planned. The doctor decides the dose and course.

Uses of Abeclib

It is not a general-purpose medicine and should only be used under cancer specialist care. It is given together with hormonal therapy such as tamoxifen or an aromatase inhibitor. It may be used in the adjuvant setting, which means after initial treatment, for early breast cancer judged to be at high risk of coming back. Whether it suits a particular patient depends on the cancer type and the specialist's assessment, so the doctor decides.

How to use Abeclib

The doctor sets the dose, the timing and how long the course lasts, and may change these based on how the patient responds and tolerates the medicine. Swallow the tablet with water. Abeclib is taken by mouth. Take Abeclib 150 mg tablet exactly as your doctor prescribes. If you miss a dose, ask your doctor or pharmacist what to do. Tell your doctor about any loose stools, fever or unusual symptoms during treatment.

Side effects of Abeclib

Because some effects can become serious, tell the doctor promptly about loose stools, fever, unusual bruising or bleeding, or any new breathing difficulty. Common side effects of Abemaciclib include diarrhea, nausea, vomiting, stomach pain, tiredness, headache, hair loss, decreased appetite and infections. Some people may develop severe diarrhea with dehydration or infection, or lung problems. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

Tell the doctor about all other medicines, since some can interact with Abemaciclib. Blood counts and symptoms need monitoring during treatment. People with diarrhea, low blood counts or lung problems need close medical monitoring.

Frequently asked questions

Why is Abeclib prescribed?

It is not a general-purpose medicine and should only be used under cancer specialist care. It is given together with hormonal therapy such as tamoxifen or an aromatase inhibitor.

How do I use Abeclib correctly?

The doctor sets the dose, the timing and how long the course lasts, and may change these based on how the patient responds and tolerates the medicine. Swallow the tablet with water.

What should I watch for while using Abeclib?

Because some effects can become serious, tell the doctor promptly about loose stools, fever, unusual bruising or bleeding, or any new breathing difficulty. Common side effects of Abemaciclib include diarrhea, nausea, vomiting, stomach pain, tiredness, headache, hair loss, decreased appetite and infections.

How much does Abeclib cost in Bangladesh?

The listed price is ৳ 950.00.

Also available as

200 mg (Tablet)

Indications

Abeclib is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • ... Read more
Abeclib is a kinase inhibitor indicated:
  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence and a Ki-67 score ≥20% as determined by an FDA approved test.
  • in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
  • in combination with fulvestrant for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
  • as monotherapy for the treatment of adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.

Pharmacology

Abemaciclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These kinases are activated upon binding to D-cyclins. In estrogen receptor-positive (ER+) breast cancer cell lines, cyclin D1 and CDK4/6 promote phosphorylation of the retinoblastoma protein (Rb), cell cycle progression, and cell proliferation. In vitro, continuous exposure to abemaciclib inhibited Rb phosphorylation and blocked progression from G1 into S phase of the cell cycle, resulting in senescence and apoptosis. In breast cancer xenograft models, abemaciclib dosed daily without interruption as a single agent or in combination with antiestrogens resulted in reduction of tumor size.

Dosage & Administration

Abemaciclib tablets are taken orally with or without food.
  • Recommended starting dose in combination with fulvestrant, tamoxifen, or an aromatase inhibitor: 150 mg twice daily.
  • Recommended starting dose as monotherapy: 200 mg twice daily.
  • Dosing interruption and/or dose reductions may be required based on individual safety and tolerability.

Interaction

CYP3A Inhibitors: Avoid concomitant use of ketoconazole. Reduce the Abeclib dose with concomitant use of other strong and moderate CYP3A inhibitors.
CYP3A Inducers: Avoid concomitant use of strong and moderate CYP3A inducers.

Side Effects

Most common adverse reactions (incidence ≥20%) were diarrhea, neutropenia, nausea, abdominal pain, infections, fatigue, anemia, leukopenia, decreased appetite, vomiting, headache, alopecia, and thrombocytopenia.

Pregnancy & Lactation

Based on findings from animal studies and the mechanism of action, Abemaciclib can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of abemaciclib to pregnant rats during the period of organogenesis caused teratogenicity and decreased fetal weight at maternal exposures that were similar to the human clinical exposure based on area under the curve (AUC) at the maximum recommended human dose. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with Abemaciclib and for 3 weeks after the last dose.

Precautions & Warnings

Diarrhea: Abeclib can cause severe cases of diarrhea, associated with dehydration and infection. Instruct patients at the first sign of loose stools to initiate antidiarrheal therapy, increase oral fluids, and notify their healthcare provider.

Neutropenia: Monitor complete blood counts prior to the start of Abeclib therapy, every 2 weeks for the first 2 months, monthly for the next 2 months, and as clinically indicated.

Interstitial Lung Disease (ILD)/Pneumonitis: Severe and fatal cases of ILD/pneumonitis have been reported. Monitor for clinical symptoms or radiological changes indicative of ILD/pneumonitis. Permanently discontinue Abeclib in all patients with Grade 3 or 4 ILD or pneumonitis.

Hepatotoxicity: Increases in serum transaminase levels have been observed. Perform liver function tests (LFTs) before initiating treatment with Abeclib. Monitor LFTs every two weeks for the first two months, monthly for the next 2 months, and as clinically indicated.

Venous Thromboembolism: Monitor patients for signs and symptoms of thrombosis and pulmonary embolism and treat as medically appropriate.

Embryo-Fetal Toxicity: Can cause fetal harm. Advise patients of potential

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Alternative brands of Abemaciclib

Other brands with the same generic name, cheapest first.

Abeza Tablet

150 mg

Abemaciclib

Beacon Pharmaceuticals PLC

৳ 950.00 per unit

Abeza Tablet

200 mg

Abemaciclib

Beacon Pharmaceuticals PLC

৳ 1150.00 per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.